文献

J-GLOBAL ID：201702285738625491   整理番号：17A1688557

ニボルマブ誘発性の急性線維素性および器質化肺炎(AFOP)

Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)

著者 (11件)： Ishiwata Tsukasa (Departments of Medical Oncology, Graduate School of Medicine, Chiba University, Japan) ,  Ishiwata Tsukasa (Department of Respirology, Graduate School of Medicine, Chiba University, Japan) ,  Ebata Takahiro (Departments of Medical Oncology, Graduate School of Medicine, Chiba University, Japan) ,  Iwasawa Shunichiro (Departments of Medical Oncology, Graduate School of Medicine, Chiba University, Japan) ,  Matsushima Jun (Department of Pathology, Graduate School of Medicine, Chiba University, Japan) ,  Ota Satoshi (Department of Pathology, Graduate School of Medicine, Chiba University, Japan) ,  Nakatani Yukio (Department of Pathology, Graduate School of Medicine, Chiba University, Japan) ,  Tsushima Kenji (Department of Respirology, Graduate School of Medicine, Chiba University, Japan) ,  Tada Yuji (Department of Respirology, Graduate School of Medicine, Chiba University, Japan) ,  Tatsumi Koichiro (Department of Respirology, Graduate School of Medicine, Chiba University, Japan) ,  Takiguchi Yuichi (Departments of Medical Oncology, Graduate School of Medicine, Chiba University, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 56  号： 17  ページ： 2311-2315(J-STAGE)  発行年： 2017年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ニボルマブは免疫関連間質性肺疾患(ILD)を引き起こすことが...

シソーラス用語： ヒト ,...
準シソーラス用語： ニボルマブ ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1688557&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (5件)： melanoma ,  nivolumab ,  pneumonitis ,  acute fibrinous and organizing pneumonia ,  bronchoalveolar lavage

分類 (1件)： 呼吸器の疾患  (GI03000Z)

引用文献 (20件)：

• 1. Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372: 320-330, 2015.
• 2. Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373: 123-135, 2015.
• 3. Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373: 1627-1639, 2015.
• 4. Abdel-Rahman O, Fouad M. Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Ther Adv Respir Dis 10: 183-193, 2016.
• 5. Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 126: 1064-1070, 2002.

タイトルに関連する用語 (3件)： ニボルマブ ,  線維素 ,  器質化肺炎